These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 6158482)

  • 1. Suppression of experimental allergic encephalomyelitis with thoracic duct lymphocytes.
    Frost H; Swanborg RH
    Int Arch Allergy Appl Immunol; 1980; 63(2):153-8. PubMed ID: 6158482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of experimental allergic encephalomyelitis by transfer of lymph node cells from Lewis rats pretreated with complete Freund's adjuvant.
    Englert D; Hempel K
    Int Arch Allergy Appl Immunol; 1981; 66(3):326-31. PubMed ID: 6170593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of experimental allergic encephalomyelitis. Part 4. Further characterization of postrecovery suppressor cells.
    Killen JA; Swanborg RH
    J Neuroimmunol; 1982 Oct; 3(2):159-66. PubMed ID: 6181092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoglobulin deficient rats as donors and recipients of effector cells of allergic encephalomyelitis.
    Willenborg DO; Sjollema P; Danta G
    J Neuroimmunol; 1986 Apr; 11(2):93-103. PubMed ID: 2419359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfer of allergic encephalomyelitis with spleen cells from donors sensitized with myelin basic protein in incomplete Freund's adjuvant.
    Namikawa T; Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):932-4. PubMed ID: 6172517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recipient contributions to serial passive transfer of experimental allergic encephalomyelitis.
    Wegmann KW; Hinrichs DJ
    J Immunol; 1984 May; 132(5):2417-23. PubMed ID: 6201543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomes containing myelin basic protein (BP) suppress but do not induce allergic encephalomyelitis in Lewis rats.
    Willenborg DO; Higgins TJ
    Aust J Exp Biol Med Sci; 1981 Apr; 59(Pt 2):135-41. PubMed ID: 6167253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic permeability of the central nervous system to mononuclear cells in experimental allergic encephalomyelitis in the Lewis rat.
    Stohl W; Gonatas NK
    J Immunol; 1978 Sep; 121(3):844-50. PubMed ID: 308523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression of experimental allergic encephalomyelitis. III. In vitro evidence for induction of suppressor T lymphocytes in draining lymph node cells of animals immunized with myelin basic protein complexed to lipopolysaccharides.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1982 May; 128(5):2073-80. PubMed ID: 6174621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the refractoriness to reinduction of experimental allergic encephalomyelitis in Lewis rats that have recovered from one episode of the disease.
    MacPhee IA; Mason DW
    J Neuroimmunol; 1990 Apr; 27(1):9-19. PubMed ID: 1690754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of experimental allergic encephalomyelitis: recipient response to myelin basic protein-reactive lymphocytes.
    Bouwer HG; Hinrichs DJ
    J Neuroimmunol; 1994 Oct; 54(1-2):87-98. PubMed ID: 7523447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the clinical and histopathologic expression of experimental allergic encephalomyelitis by the vasoactive amine antagonist cyproheptadine.
    Waxman FJ; Taguiam JM; Whitacre CC
    Cell Immunol; 1984 Apr; 85(1):82-93. PubMed ID: 6201289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of paralytic experimental allergic encephalomyelitis in rats: susceptibility to active and passive disease reinduction.
    Hinrichs DJ; Roberts CM; Waxman FJ
    J Immunol; 1981 May; 126(5):1857-62. PubMed ID: 6163820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of Lewis rats to experimental autoimmune encephalomyelitis after recovery from passively induced disease.
    Holda JH; Swanborg RH
    Immunol Commun; 1980; 9(4):333-40. PubMed ID: 6157638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of experimental allergic encephalomyelitis. III. Demonstration of effector cells in tolerant rats.
    Holda JH; Swanborg RH
    Eur J Immunol; 1981 Apr; 11(4):338-40. PubMed ID: 6166483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of experimental allergic encephalomyelitis. II. Appearance of suppressor cells during the remission phase of the disease.
    Welch AM; Holda JH; Swanborg RH
    J Immunol; 1980 Jul; 125(1):186-9. PubMed ID: 6155396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune effector cells. VII. Cells isolated from thymus and spinal cord of rats with experimental allergic encephalomyelitis transfer disease.
    Hayosh NS; Swanborg RH
    Am J Pathol; 1986 Feb; 122(2):218-22. PubMed ID: 2418687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of acute experimental allergic encephalomyelitis in guinea pigs by prior transfer of suboptimal numbers of EAE-effector cells: induction of chronic EAE in whole tissue-sensitized guinea pigs.
    Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1982 Feb; 128(2):635-8. PubMed ID: 6172501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Experimental allergic encephalomyelitis in Lewis rats: inhibition by bacterial lipopolysaccharides and acquired resistance to reinduction by challenge with myelin basic protein.
    Raziuddin S; Kibler RF; Morrison DC
    J Immunol; 1981 Jul; 127(1):16-20. PubMed ID: 6165759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.